Delivery Order SPE2DR25D1004-SPE2DR26FSUK0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of 500 tablets of Citalopram HBr 10 mg, valued at $1,012.71. This is a firm fixed-price delivery order with an ultimate completion date of November 7, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is a child contract under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Citalopram HBr 10 mg tablets (500 count) with a ceiling value of $6,228.15. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is set for ultimate completion by October 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Citalopram is a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 20 mg tablets (500-unit quantity) on October 28, 2025, with an ultimate completion date of October 29, 2025. This competitively awarded, firm fixed-price contract carries a ceiling value of $1,023.19 and involves no set-aside designation. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 40 mg tablets (500 count) valued at $33,841.22 under a firm fixed-price contract type. The award was made on July 23, 2025, with an ultimate completion date of July 24, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania serves as the place of performance for this delivery order. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 40 mg tablets in quantities of 500 units, with a contract ceiling value of $11,360.96. The award, issued on April 24, 2025, represents a firm fixed-price delivery order with an ultimate completion date of April 25, 2025. The contract is not set-aside and was awarded through competitive procurement, demonstrating AmerisourceBergen's capability to meet federal pharmaceutical supply...
- The Defense Logistics Agency awarded a $16,451.57 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of 500 tablets of Citalopram HBR 40 mg, with completion expected by September 5, 2025. This competitively awarded contract utilizes firm fixed-price pricing and carries no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Citalopram HBr 20 mg tablets (500 count) with a ceiling value of $5,066.63. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively through open procurement. The contract specifies a performance location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The ultimate completion date is set...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $66,046.37 on September 29, 2025, for the supply of Citalopram HBR 20 mg tablets in quantities of 500. The contract employs firm fixed pricing and is scheduled for completion by September 30, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. This is a non-set-aside award, indicating the contract was competitively awarded to the vendor through open...
- The Defense Logistics Agency awarded a delivery order valued at $10,959.19 to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 40 mg tablets (500 count) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreements with the agency. The product will be delivered to the company's facility in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,158.43 to AmerisourceBergen Drug Corp for 500 tablets of Citalopram HBR 40 mg. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, due for completion by August 18, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award falls under the company's larger...
- SPE2DR25D1004Indefinite Delivery Contract
- SPE2DR25D1004-SPE2DR26FSUK0Delivery Order
The Defense Logistics Agency awarded a $2,619.18 delivery order to AmerisourceBergen Drug Corp for 500 tablets of Citalopram HBR 40 mg on November 4, 2025, with an ultimate completion date of November 5, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a single delivery order under a larger indefinite delivery contract vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's prime indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. As a selective serotonin reuptake inhibitor (SSRI) antidepressant medication, citalopram falls within the company's extensive portfolio of therapeutic medications routinely delivered to support federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 11/4/25 |